FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB – A TRANSITION LEADING TO CHANGES?
Maria José Temido 1
Andrea Emília Pereira Silva 1
Mafalda João 2
Raquel Pimentel 2
Catarina Correia 2
Sandra Lopes 2
Sofia Mendes 2
Pedro Narra Figueiredo 2
Francisco Silva Portela 2
1 Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
2 Portuguese Oncology Institute of Coimbra, Coimbra, Portugal
Session
IBD (Posters)
Conference
UEG Week 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]